AstraZeneca Malaysia has won the Sponsor of the Year Award from Clinical Research Malaysia (CRM) for contributing to the highest number of clinical studies in 2023.
Organised by CRM, the CRM Sponsorship Research Awards 2024 acknowledges the accomplishments of Malaysia’s clinical research industry as well as honours clinical research professionals and industry players who have significantly contributed to the conduct of clinical trials in Malaysia. In addition, AstraZeneca’s contributions to ‘First in-human’ and AI-related studies were recognised as an Acknowledgement of Partnership.
To read more on how AstraZeneca’s clinical research has contributed to Malaysia, click here.